{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:37:54Z","timestamp":1792715874451,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["Projet de Recherche Enfants, Adolescents et Cancer"],"award-info":[{"award-number":["Projet de Recherche Enfants, Adolescents et Cancer"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.esmoop.2026.108539","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:09:53Z","timestamp":1789430993000},"page":"108539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights into rhabdomyosarcoma in the adolescent and young adult population: a comprehensive clinical study from the French Society of Pediatric Oncology (SFCE) Malignant Mesenchymal Tumor (MMT) Committee and the French Sarcoma Group (GSF-GETO)"],"prefix":"10.1016","volume":"11","author":[{"given":"C.","family":"Khanfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sevrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8788-6737","authenticated-orcid":false,"given":"E.","family":"Bogart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Karanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2808-4843","authenticated-orcid":false,"given":"L.","family":"Fenwarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-120X","authenticated-orcid":false,"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cleirec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Le Deley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Le Cesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Thanayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ducoulombier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-9274","authenticated-orcid":false,"given":"M.","family":"Toulmonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2889-685X","authenticated-orcid":false,"given":"F.","family":"Ducimetiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Coindre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cantaloube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-5875","authenticated-orcid":false,"given":"H.","family":"Brisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Minard-Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-S.","family":"Defachelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2026.108539_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejca.2018.12.031","article-title":"Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors","volume":"110","author":"Ferrari","year":"2019","journal-title":"Eur J Cancer"},{"issue":"20","key":"10.1016\/j.esmoop.2026.108539_bib2","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1200\/JCO.2008.19.7483","article-title":"Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients","volume":"27","author":"Sultan","year":"2009","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.esmoop.2026.108539_bib3","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1200\/JCO.2018.77.9694","article-title":"Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the Children\u2019s Oncology Group","volume":"36","author":"Hawkins","year":"2018","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108539_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(18)30337-1","article-title":"Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"19","author":"Bisogno","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5-6","key":"10.1016\/j.esmoop.2026.108539_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00508-004-5-0285-8","article-title":"Treatment for soft tissue sarcoma in childhood and adolescence: Austrian results within the CWS 96 study","volume":"117","author":"Modritz","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108539_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.2007.12.2382","article-title":"Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma","volume":"26","author":"Dantonello","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108539_bib7","first-page":"4485","article-title":"The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients: a multicenter study","volume":"32","author":"Van Gaal","year":"2012","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108539_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/cam4.92","article-title":"Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients","volume":"2","author":"Dumont","year":"2013","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108539_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12032-019-1282-0","article-title":"Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series","volume":"36","author":"Bergamaschi","year":"2019","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108539_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijrobp.2012.12.016","article-title":"Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols","volume":"86","author":"Gerber","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108539_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2352-4642(22)00121-3","article-title":"Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study","volume":"6","author":"Ferrari","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108539_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jayao.2020.0043","article-title":"Impact of rhabdomyosarcoma treatment modalities by age in a population-based setting","volume":"10","author":"Ferrari","year":"2021","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108539_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.surg.2017.10.027","article-title":"Pediatric-protocol of multimodal therapy is associated with improved survival in AYAs and adults with rhabdomyosarcoma","volume":"163","author":"Fischer","year":"2018","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108539_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.26355","article-title":"Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee","volume":"118","author":"Bisogno","year":"2012","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108539_bib15","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3390\/cancers12082057","article-title":"Targeting the tumor microenvironment in neuroblastoma: recent advances and future directions","volume":"12","author":"Joshi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108539_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1097-0142(20010215)91:4<794::AID-CNCR1066>3.0.CO;2-Q","article-title":"Clinicopathologic analysis of patients with adult rhabdomyosarcoma","volume":"91","author":"Hawkins","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108539_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cncr.11550","article-title":"Rhabdomyosarcoma in adults: a retrospective analysis of 171 patients treated at a single institution","volume":"98","author":"Ferrari","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108539_bib18","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S1470-2045(17)30099-2","article-title":"Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts","volume":"18","author":"van der Graaf","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108539_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27013","article-title":"The challenge of the management of adolescents and young adults with soft tissue sarcomas","volume":"65","author":"Ferrari","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108539_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/PPO.0000000000000337","article-title":"Challenges of clinical management of adolescent and young adults with bone and soft tissue sarcoma","volume":"24","author":"Ferrari","year":"2018","journal-title":"Cancer J Sudbury Mass"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108539_bib21","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3390\/cancers14092270","article-title":"Optimizing rhabdomyosarcoma treatment in adolescents and young adults","volume":"14","author":"Makimoto","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108539_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30905","article-title":"The AYA gap for rhabdomyosarcoma","volume":"71","author":"Hettmer","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108539_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30847","article-title":"Adolescents and young adults with rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children\u2019s Oncology Group","volume":"71","author":"Harrison","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.esmoop.2026.108539_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102398","article-title":"Impact of age on survival according to molecular tumor findings in children and adolescents with soft-tissue and bone sarcoma: the BIOSCA project","volume":"92","author":"Desandes","year":"2024","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108539_bib25","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1470-2045(16)00162-5","article-title":"Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5","volume":"17","author":"Trama","year":"2016","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108539_bib26","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/cam4.1374","article-title":"Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study","volume":"7","author":"Bompas","year":"2018","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108539_bib27","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X","article-title":"The intergroup rhabdomyosarcoma study-II","volume":"71","author":"Maurer","year":"1993","journal-title":"cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108539_bib28","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S1470-2045(19)30617-5","article-title":"Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Bisogno","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2026.108539_bib29","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/cncr.10492","article-title":"TNM residual tumor classification revisited","volume":"94","author":"Wittekind","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108539_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108539_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.esmoop.2026.108539_bib32","doi-asserted-by":"crossref","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108539_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jayao.2020.0017","article-title":"Cancer among adolescents and young adults between 2000 and 2016 in France: incidence and improved survival","volume":"10","author":"Raze","year":"2021","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108539_bib34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.5858\/arpa.2014-0475-OA","article-title":"The World Health Organization classification of skeletal muscle tumors in pediatric rhabdomyosarcoma","volume":"139","author":"Rudzinski","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108539_bib35","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1038\/ncomms8557","article-title":"Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma","volume":"6","author":"Seki","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108539_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.critrevonc.2011.06.005","article-title":"Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead","volume":"82","author":"Van Gaal","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108539_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bulcan.2020.10.009","article-title":"Management of sarcomas in children, adolescents and adults: interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network","volume":"108","author":"Bompas","year":"2021","journal-title":"Bull Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108539_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100096","article-title":"Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)","volume":"6","author":"Ferrari","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.esmoop.2026.108539_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ctrv.2018.06.013","article-title":"Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned","volume":"68","author":"Arndt","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108539_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26348","article-title":"Access to clinical trials for adolescents with soft tissue sarcomas: enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols","volume":"64","author":"Ferrari","year":"2017","journal-title":"Pediatr Blood Cancer"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:41:32Z","timestamp":1792712492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926024841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2059702926024841"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108539","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into rhabdomyosarcoma in the adolescent and young adult population: a comprehensive clinical study from the French Society of Pediatric Oncology (SFCE) Malignant Mesenchymal Tumor (MMT) Committee and the French Sarcoma Group (GSF-GETO)","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108539"}}